Gyejijakyakjimo-tang is a multi-herbal formula that is composed of nine medicinal herbs. Gyejijakyakjimo-tang has been reported to have antipyretic and analgesic effects. Gyejijakyakjimo-tang has traditionally been used for goat and rheumatoid arthritis. However, analgesic and antiinflammatory effects of Gyejijakyakjimo-tang has not been clarified yet. In this study, we investigated the analgesic and anti-inflammatory effect of the aqueous extract of Gyejijakyakjimo-tang. We evaluated the aqueous extract of Gyejijakyakjimo-tang on Lipopolysaccharide (LPS)-induced inflammation in murine raw 264.7 macrophage cells. For this study, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, reverse transcription-polymerase chain reaction (RT-PCR), prostaglandin E 2 (PGE 2 ) immunoassay, and nitric oxide (NO) detection were performed. Gyejijakyakjimo-tang suppressed PGE 2 synthesis and NO production by inhibiting the LPS-induced expressions of COX-2 and iNOS mRNA in murine raw 264.7 macrophage cells. These results show that Gyejijakyakjimo-tang has the analgesic and anti-inflammatory effect by mostly suppressing COX-2 and iNOS expressions, and resulting in the inhibition of PGE 2 synthesis and NO production.
INTRODUCTION
Inflammation is a complex process which commences with a primary reaction in tissues. Cardinal signs of inflammation are heat, redness, swelling, and pain. Of these, pain is important clues of immunological activity (McGeer and McGeer, 1995) . Lipopolysaccharide (LPS) initiates a number of major cellular responses that play vital roles in the pathogenesis of inflammatory responses. LPS expresses the production of inflammatory mediators, such as nitric oxide (NO), tumor necrosis factor-α (TNF-α), interleukins, prostaglandin E 2 (PGE 2 ), and leukotrienes (Lee et al., 1992; Kubes and McCafferty, 2000) .
PGE 2 mediates the important features at inflammatory sites where it contributes to local blood flow increases, edema, and pain sensitization . PGE 2 is converted from arachidonic acid by cyclooxygenase (COX). There are two isoforms of COX: COX-1 and COX-2. While COX-1 is a constitutively expressed form in normal physiologic function, COX-2 is expressed by proinflammatory mediators and mitogenic stimuli including cytokines, endotoxins, and growth factors Kyoung-Su Park et al. (Surh et al., 2001) .
As a neuromodulator, NO is an important physiological messenger and effector molecule in many biological systems, including immunological, neuronal and cardiovascular tissues (Bredt and Snyder, 1994) . NO is produced by nitric oxide synthase (NOS) enzyme as a by conversion of L-arginine to L-citrulline. Three types of NOS have been identified: endothelial NOS (eNOS), inducible NOS (iNOS), and neuronal NOS (nNOS) (Moalem and Tracey, 2006) . Of these, iNOS is an important enzyme involved in the regulation of inflammation (Yui et al., 1991) .
Gyejijakyakjimo-tang is composed of nine medicinal plants, including Atractylodis Rhizoma(白朮), Aconiti Tuber(附子), Glycyrrhizae Radix(甘草), Paeoniae Radix( 芍藥 ), Cinnamomi cassiae Ramulus( 桂枝), Ephedrae Herba(麻黃), Zingiberis Rhizoma(生薑), Ledebouriellae Radix(防風), and Anemarrhenae Rhizoma(知母). Following traditional medical literatures, Gyejijakyakjimo-tang has been reported to have antipyretic and analgesic effect. That's why it has been mainly used to treat gout, rheumatoid arthritis . However, the effect of Gyejijakyakjimotang on analgesic and anti-inflammatory has not been clarified yet.
In this study, we investigated the analgesic and anti-inflammatory effect of the aqueous extract of Gyejijakyakjimo-tang. We evaluated the effect of the aqueous extract of Gyejijakyakjimo-tang on LPS-induced inflammation in murine raw 264.7 macrophage cells. For this study, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, reverse transcription-polymerase chain reaction (RT-PCR), PGE 2 immunoassay, and NO detection were performed.
MATERIALS AND METHODS

Cell culture
Murine raw 264.7 macrophage cells were cultured in Dulbecco's modified Eagle's Medium (DMEM; Gibco BRL, Grand Island, NY, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gibco BRL, Grand Island, NY, USA) at 37°C in 5% CO 2 in a humidified cell incubator. The cells were plated onto culture dishes at a density of 2 × 10 4 cells/cm 2 24 h prior to drug treatments.
Preparation of the aqueous extract of Gyejijakyakjimotang Gyejijakyakjimo-tang was composed of nine medicines: 30 g Atractylodis Rhizoma, 6 g Aconiti Tuber, 12 g Glycyrrhizae Radix, 18 g Paeoniae Radix, 24 g Cinnamomi cassiae Ramulus, 12 g Ephedrae Herba, 30 g Zingiberis Rhizoma, 24 g Ledebouriellae Radix, and 24 g Anemarrhenae Rhizoma. Total 180 g of dried ingredients was added to distilled water, and extraction was performed by heating at 90°C for 2 h, concentrating with rotary evaporator (Eyela, Tokyo, Japan) and lyophilizing by a drying machine (Eyela, Tokyo, Japan) for 24 h. The resulting powder, weighting 32.5 g (yield of 18.06%) was diluted to the concentrations needed with autoclaved distilled water and filtered through a 0.22 μm syringe filter before use.
MTT cytotoxicity assay
Murine raw 264.7 macrophage cells were grown in a final volume of 100 μl culture medium per well in 96-well plates. In order to determine the cytotoxicity of Gyejijakyakjimo-tang, the cells were treated with Gyejijakyakjimo-tang at concentrations of 1 μg/ml, 10 μg/ml, 100 μg/ml, 1,000 μg/ml, and 10,000 μg/ml for 24 h. Cultures of the cells of the control group were left untreated. After adding 10 µl of the MTT labeling reagent containing 5 mg/ ml MTT in phosphate-buffered saline to each well, the plates were incubated for 2 h. Solubilization solution 100 µl containing 10% sodium dodecyl sulfate in 0.01 M hydrochloric acid was added to each well, and the cells were incubated for another 12 h. 
RNA isolation and RT-PCR
To identify the expression of COX-2 and inducible iNOS mRNA, RT-PCR was performed. The total RNA was isolated from murine raw 264.7 macrophage cells using RNAzol TM B (TEL-TEST, Friendswood, TX, USA). One μg of RNA and 2 μl of random hexamers (Promega, Madison, WI, USA) were added together, and the mixture was heated at 65°C for 15 min. 1 μl of AMV reverse transcriptase (Promega), 5 μl of 2.5 mM dNTP (Promega), 0.5 μl of RNasin (Promega), and 8 μl of 5 × AMV RT buffer (Promega) were then added to the mixture, and the final volume was brought up to 40 μl volume with diethylpyrocarbonate (DEPC)-treated water. The reaction mixture was then incubated at 42°C for 2 h.
PCR amplification was performed in a reaction volume of 40 μl containing 2 μl of the appropriate cDNA, 0.5 μl of each set of primers at a concentration of 10 pM, 4 μl of 10 × RT buffer, 1 μl of 2.5 mM dNTP, and 0.2 units of Taq DNA polymerase (Takara, Shiga, Japan). For mouse COX-2, the primer sequences were 5'-CCAGATGCTATCTTTGGGGAGAC-3' (a 23-mer sense oligonucleotide) and 5'-CTTGCATTGA-TGGTGGCTG-3' (a 19-mer anti-sense oligonucleotide). For mouse iNOS, the primer sequences were 5'-CAAGAGTTTGACCAGAG-GACC-3' (a 21-mer sense oligonucleotide) and 5'-TGGAACCACTCGTAC-TTGGGA-3' (a 21-mer anti-sense oligonucleotide). For cyclophilin, the internal control used in the study, the primer sequences were 5'-ACCCCACCGTGT-TCTTCGAC-3' (a 20-mer sense oligonucleotide) and 5'-CATTTGCCATGGACAAGATG-3' (a 20-mer anti-sense oligonucleotide). Gene-specific PCR primers were selected with the following NCBI database Accession NOS.: COX-2 (NM_011198), iNOS (NM_010927), and cyclophilin (NM_001008741).
For COX-2, the PCR procedures was carried out using a PTC-0150 MiniCycler (Bio-Rad, Hercules, CA, USA) under the following conditions: initial denaturation at 94°C for 5 min, followed by 30 amplification cycles, each consisting of denaturation at 94°C for 30 s, annealing at 58°C for 30 s, and extension at 72°C for 30 s, with an additional extension step at the end of the procedure at 72°C for 10 min. For iNOS, the PCR procedures was under the following conditions: initial denaturation at 94°C for 5 min, followed by 30 amplification cycles, each consisting of denaturation at 94°C for 30 s, annealing at 60°C for 30 s, and extension at 72°C for 45 s, with an additional extension step at the end of the procedure at 72°C for 10 min. For cyclophilin, under the following conditions: initial denaturation at 94°C for 5 min, followed by 25 amplification cycles, each consisting of denaturation at 94°C for 30 s, annealing at 58°C for 30 s, and extension at 72°C for 45 s, with an additional extension step at the end of the procedure at 72°C for 10 min. The final amount of RT-PCR product for each of the mRNA species was calculated densitometrically using Imaging-Pro ® Plus (Media Cyberbetics Inc., Silver Spring, MD, USA).
Determination of nitric oxide production
In order to determine effect of the aqueous extract of Gyejijakyakjimo-tang on NO production, the amount of nitrite in the supernatant was measured using a commercially available NO detection kit (iNtRON, INC., Seoul, Korea). After collection of 100 μl of supernatant, 50 μl of N1 buffer was added to each well, and the plate was incubated at room temperature for 10 min. N2 buffer was then added, and the plate was incubated at room temperature for 10 min. The absorbance of the content of each well was measured at a wavelength of 540 nm. The nitrite concentration was calculated from a nitrite standard curve.
Measurement of prostaglandin E2 synthesis
Assessment of PGE 2 synthesis was performed Kyoung-Su Park et al.
using a commercially available PGE 2 competitive enzyme immunoassay kit (Amersham Pharmacia Biotech. Inc., Piscataway, NJ, USA). Supernatant 100 μl from the culture medium and the standards were put into different wells on the goat antimouse IgG-coated microtiter plate provided in the kit. Mouse anti-PGE 2 antibody and peroxidaseconjugated PGE 2 were added to each well, and the plate was incubated at room temperature with shaking for 2 h. The wells were drained and washed, and 3,3',5,5'-tetramethylbenzidine/hydrogen peroxide solution was then added. The plate was incubated at room temperature with shaking, and the reaction was stopped after 30 min through the addition of H 2 SO 4 . The absorbance of the content of each well was then measured at a wavelength of 450 nm.
Statistical analysis
The results are presented as the mean ± standard error of the mean (S.E.M.). The data were analyzed by one-way ANOVA followed by Duncan's posthoc test using SPSS. The differences were considered statistically significant at P < 0.05.
RESULTS
Effect of the aqueous extract of Gyejijakyakjimotang on viability of murine raw 264.7 macrophage cells In order to assess the cytotoxic effect of the aqueous extract of Gyejijakyakjimo-tang on the murine raw 264.7 macrophage cells, the cells were cultured with the aqueous extract of Gyejijakyakjimo-tang at final concentrations of 1 μg/ml, 10 μg/ml, 100 μg/ml, 1,000 μg/ml, 10,000 μg/ml for 24 h, and MTT assays was then carried out. The cells cultured in Gyejijakyakjimo-tang-free media were used as the control. The viability of cells incubated with Gyejijakyakjimo-tang at concentrations of 1 μg/ml, 10 μg/ml, 100 μg/ml, 1,000 μg/ml, 10,000 μg/ml for 24 h was 98.56 ± 1.91%, 94.90 ± 2.38%, 90.06 ± 1.32%, 77.05 ± 1.02%, 23.09 ± 1.34% of the control value, respectively (Fig. 1) .
The present results showed that the aqueous extract of Gyejijakyakjimo-tang exerted no cytotoxicity until it was at a concentration of 100 μg/ml. However, at high concentrations (1,000 and 10,000 μg/ml) of Gyejijakyakjimo-tang reduced cell viability. Then, we used the aqueous extract of Gyejijakyakjimo-tang at concentration of 10 and 100 μg/ml for the next experiments.
Effect of the aqueous extract of Gyejijakyakjimotang on NO production From the NO detection assay, the amount of nitrite was increased from 1.67 ± 0.15 μM to 25.64 ± 0.66 μM after 24 h of exposure to LPS. NO production was decreased to 22.57 ± 0.55 μM, 20.90 ± 0.93 μM, and 18.52 ± 0.30 μM by pre-treatment for 1 h with the aqueous extract of Gyejijakyakjimo-tang at 10 μg/ml, Fig. 1 . Effect of Gyejijakyakjimo-tang on murine raw 264.7 macrophage cell viability. The cells were pre-treated for 1 h with Gyejijakyakjimo-tang at concentrations of 0.001 mg/ml, 0.01 mg/ml, 0.1 mg/ml, 1 mg/ml, and 10 mg/ml, then 1 μg/ml LPS was treated for 24 h. The cells were incubated for 24 h. Cells were stained MTT and analyzed by enzyme-linked immunosorbent assay (ELISA). The experiments were repeated four times. (A) Control group, (B) 0.001 mg/ml Gyejijakyakjimotang -treated group, (C) 0.01 mg/ml Gyejijakyakjimotang -treated group, (D) 0.1 mg/ml Gyejijakyakjimotang -treated group, (E) 1 mg/ml Gyejijakyakjimo-tang -treated group, (F) 10 mg/ml Gyejijakyakjimo-tang -treated group. Results are presented as mean ± S.E.M. * P < 0.05 compared to the control. 100 μg/ml, and 400 μM ASA, following LPS treatment for 24 h (Fig. 2) .
The present results showed that LPS enhanced NO production in murine raw 264.7 macrophage cells and the aqueous extract of Gyejijakyakjimotang suppressed LPS-induced NO production.
Effect of the aqueous extract of Gyejijakyakjimotang on PGE 2 synthesis From PGE 2 immunoassay, the amount of PGE 2 from the culture medium was increased from 21.68 ± 0.01 pg/ml to 53.86 ± 0.88 pg/ml after 24 h of exposure to LPS. PGE 2 synthesis was decreased to 54.96 ± 0.54 pg/ml, 43.97 ± 1.32 pg/ml, and 38.36 ± 1.23 pg/ml by the pre-treatment for 1 h with the aqueous extract of Gyejijakyakjimo-tang at 10 μg/ml, 1,00 μg/ml, and 400 μM ASA, following 1 μg/ml LPS treatment for 24 h (Fig. 3) .
The present results showed that LPS enhanced PGE 2 synthesis in murine raw 264.7 macrophage cells and the aqueous extract of Gyejijakyakjimotang suppressed LPS-induced PGE 2 synthesis.
Effect of the aqueous extract of Gyejijakyakjimotang on mRNA expressions of COX-2 and iNOS RT-PCR analysis of the mRNA levels of COX-2 and iNOS was performed to estimate the relative level of expressions of these genes. In the present study, the mRNA levels of COX-2 and iNOS in the control cells were set as 1.00. The level of COX-2 mRNA was markedly increased to 6.93 ± 0.29 following a treatment with 1 μg/ml LPS for 24 h. The level of COX-2 mRNA was decreased to 5.31 ± 0.90, 3.99 ± 0.80, and 3.05 ± 0.50 in the cells pre-treated for 1 h with the aqueous extract of Gyejijakyakjimo-tang at 10 μg/ml, 100 μg/ml, and 400 μM ASA, following LPS treatment for 24 h.
The level of iNOS mRNA following a treatment synthesis in murine raw 264.7 macrophage cells. The cells were pre-treated for 1 h with Gyejijakyakjimo-tang at concentrations of 0.01 mg/ml, and 0.1 mg/ml, then 1 μg/ml LPS was treated for 24 h. The cells were incubated for 24 h. Total PGE 2 were detected and analyzed by enzymelinked immunosorbent assay (ELISA). The experiments were repeated four times. A, Control; B, LPS-treated group; C, LPS-and 0.01 mg/ml Gyejijakyakjimo-tangtreated group; D, LPS-and 0.1 mg/ml Gyejijakyakjimotang-treated group; E, LPS-and 400 μM acetylsalicylic acid-treated group. Results are presented as mean ± S.E.M. with 1 μg/ml LPS for 24 h was markedly increased to 4.21 ± 0.58. The level of iNOS mRNA was decreased to 2.78 ± 0.37, 2.00 ± 0.38, and 1.69 ± 0.36 in the cells pre-treated for 1 h with the aqueous extract of Gyejijakyakjimo-tang at 10 μg/ml, 100 μg/ml, and 400 μM ASA, following LPS treatment for 24 (Fig. 4) .
The present results showed that LPS enhanced COX-2 and iNOS mRNA expressions in murine raw 264.7 macrophage cells and the aqueous extract of Gyejijakyakjimo-tang suppressed LPS-induced COX-2 and iNOS mRNA expressions.
DISCUSSION
Geyjijakyakgimo-tang was originally discussed in the quotation "諸肢節疼痛 身體 羸 脚腫如脫 頭 眩短氣 溫溫欲吐 桂枝芍藥知母湯主之" Jinguiyaolue (金 要略 ). Since early times, Geyjijakyakgimo-tang has been used for arthralgia syndrome (bi-zheng, 痺 證), li-jie-feng (歷節風) or gout (tong-feng, 痛風 ) (Li, 1989) .
In domestic research of the past use of Gyejijakyakjimo-tang, it was reported effects of pain reduction, relaxation, removal of fever, antiedema, blood vessel permeable suppression and white corpuscle wandering suppression in the male rats and decrease in Ig G anti-collagen antibody (Lee and Shin, 1990) . It was reported the effect of pain reduction and anti-edema and it increases the uric acid emission, and has an effect on decrease of blood uric acid although it is not involved in uric acid metabolism . In overseas studies, reported a decrease in ESR and CRP after treatment for clinical Rhematoid arthritis patients (Guo et al., 2006) . Of C57BL/6 mice, Zhang reported that in Type II collagen induced arthritis, it suppresses the increase of RA T-Lymphocyte, RA IL-2 and CRP (Zhang , 2005; Zhang, 2006) , and it suppresses the increase of TNF-α, IL-1β (Yue et Fig. 4 . Results of RT-PCR analysis of the mRNAs level of COX-2 and iNOS. Murine raw 264.7 macrophage cells were pre-treated for 1 h with Gyejijakyakjimo-tang at concentrations of 0.01 mg/ml, and 0.1 mg/ml, then 1 μg/ml LPS was treated for 24 h. RNA were extracted and subjected to RT-PCR analysis for the mRNA expressions of COX-2 and iNOS. The experiments were repeated four times. (A) Control group, (B) LPS-treated group, (C) LPSand 0.01 mg/ml Gyejijakyakjimo-tang -treated group, (D) LPS-and 0.1 mg/ml Gyejijakyakjimo-tang -treated group, (E) LPS-and 400 μM acetylsalicylic acid-treated group. Cyclophilin mRNA was used as the internal control. Results are presented as mean ± S.E.M. 
al., 2005).
Injury and infection stimulate immune system to produce an inflammatory response (Dickerson et al., 1998) . With inflammatory diseases, the macrophages produce excess amounts of mediators such as NO, prostanoids and pro-inflammatory cytokines .
In recent studies, we found that the aqueous extract of Gyejijakyakjimo-tang significantly suppressed LPS-induced COX-2 expression and PGE 2 synthesis in murine raw 264.7 macrophage cells. One such enzyme that is particularly important in regards to inflammation is COX. Elevated level of COX-2 expression has been detected in various tumor types, and may account for the excessive production of inflammatory prostaglandins. Specific COX-2 inhibitors are known to attenuate the symptoms of inflammation (Shao et al., 2000) . Myers et al. reported that mice deficient in COX-2 displayed significant reduction in synovial inflammation and joint deterioration in a collagen-induced arthritis model (Myers et al., 2000) . Kim et al. showed that the COX-2 inhibitor has a beneficial effect in the treatment of mast cell-mediated inflammatory allergy disease .
In recent results, we find that the aqueous extract of Gyejijakyakjimo-tang significantly inhibited LPSinduced iNOS expression and NO production in murine raw 264.7 macrophage cells. NO is a shortlived free radical that mediates many biological functions, including neurotransmission, vascular homeostasis, and host defense (Moncada et al., 1991; Jaffrey and Snyder, 1995) . Overproduction of NO by iNOS has been linked to circulatory shock (Szabo, 1995) , inflammation (MacMicking et al., 1997) , and carcinogenesis (Ohshima and Bartsch, 1994) . Thus, inhibition of NO production by blocking iNOS expression is an important benefit in the treatment of inflammatory diseases. Recently, Cuzzocrea et al. reported that selective inhibitors of iNOS activity have potent effect on collageninduced arthritis in rodent model (Cuzzocrea et al., 2002) .
Many herbal plants are used in the treatment of inflammation in traditional medicine (Talhouk et al., 2007) . Herbal medicine has several different pharmacological properties, because synergistic effects between herbs can occur Nishizawa et al., 1995; Jang et al., 2003) . The herbal constituents are selected to accentuate the therapeutic actions, to enhance the activity of component compounds in clinical application, and reduce the toxicity or other side effects of the compounds (Bansky and Barolet, 1990; Oh et al., 2005) . Gyejijakyakjimo-tang is a formula prescription that has been used to treat goat and rheumatoid arthritis. Gyejijakyakjimo-tang is composed of nine medicinal plants. Of these, Ledebouriellae Radix has anti-nociceptive and anti-inflammatory effects on Freund's adjuvant-induced arthritis in rats (Kim et al., 2002) . Aconiti Tuber exerts the anti-nociceptive effect by stimulating kappa-opioid receptors (Omiya et al., 1999) . Bioactive glucoside from Paeoniae Radix suppressed production of interleukin-1 (IL-1), PGE 2 , IL-6, vascular epidermal growth factor (VEGF), granulocyte macrophage colony stimulating factor (GM-CSF) in synoviocyte of the rats with adjuvant arthritis (Zheng et al., 2007) . Zingiberis Rhizoma has an analgesic effect related to the inhibition of prostaglandin and leukotriene biosynthesis (Srivastava and Mustafa, 1992) . Of significance, it was reported that with Atractylenolid I and Atractylenolid III, the components of Atractylodis Rhizoma, inhibited LPS-induced TNF-α and NO production in macrophages (Li et al., 2007) .
In this study, we have shown that the aqueous extract of Gyejijakyakjimo-tang exerts analgesic and anti-inflammatory effects by mostly suppressing COX-2 and iNOS expressions, and resulting in the inhibition of PGE 2 and NO production.
CONCLUSION
In this study, we investigated the analgesic and anti-inflammatory effect of the aqueous extract of Gyejijakyakjimo-tang by using in vitro and vivo studies. In vitro study, we evaluated the aqueous extract of Gyejijakyakjimo-tang on LPS-induced inflammation in murine raw 264.7 macrophage cells. Gyejijakyakjimo-tang suppressed PGE 2 synthesis and NO production by inhibiting the LPS-induced expressions of COX-2 and inducible iNOS mRNA in murine raw 264.7 macrophage cells. These results show that Gyejijakyakjimo-tang has the analgesic and anti-inflammatory effect by mostly suppressing COX-2 and iNOS expressions, and resulting in the inhibition of PGE 2 synthesis and NO production.
